AMCP Market Insights: Impact of the evolving understanding of multiple sclerosis and emerging treatment approaches on managed care

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS) and is associated with significant clinical and economic burden. Advancements in the understanding of the underlying biology of MS have important implications for both diagnosis and treatment. To discuss the impact of continuing developments in MS on managed care, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in December 2024. Key insights from the discussion related to supporting patient needs in MS, advancing understanding of MS, emerging treatments in MS, using real-world evidence in MS coverage decision-making, and addressing continued challenges in MS. Suggested payer best practices in MS also emerged from the discussion.